{"transactions":[{"id":3228306,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHIEF BUSINESS OFFICER"}}],"security":"Restricted Stock Units","published_at":"2020-03-04T19:30:24.000Z","date":"2020-01-30","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the restricted stock units issued to the reporting person on January 30, 2019 which have partially vested and settled for shares of the issuer's common stock.\nThe original Form 4 filed on January 31, 2020 is amended in its entirety by this Form 4 Amendment to provide the: (a) correct date the restricted stock units were first issued to the reporting person; and (b) correct disposition of the derivative securities."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"The original Form 4 filed on January 31, 2020 is amended by this Form 4 Amendment to correctly identify the nature of the transaction of the reporting person"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the restricted stock units issued to the reporting person on January 30, 2019 which have partially vested and settled for shares of the issuer's common stock.\nThe original Form 4 filed on January 31, 2020 is amended in its entirety by this Form 4 Amendment to provide the: (a) correct date the restricted stock units were first issued to the reporting person; and (b) correct disposition of the derivative securities."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reflects the restricted stock units issued to the reporting person on January 30, 2019 which have partially vested and settled for shares of the issuer's common stock.\nThe original Form 4 filed on January 31, 2020 is amended in its entirety by this Form 4 Amendment to provide the: (a) correct date the restricted stock units were first issued to the reporting person; and (b) correct disposition of the derivative securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The remaining restricted stock units will vest ratably each quarter through January 30, 2023, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001415889-20-000638","document":"form4a-03042020_020311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000638/form4a-03042020_020311.xml","form_type":"4/A","original_submission_date":"2020-01-31"}},{"id":3228305,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2020-03-04T19:30:24.000Z","date":"2020-01-30","kind":"tax_withholding","acquired":false,"shares":2045,"price":3.91,"value":7995.95,"ownership":{"direct":true},"balance_after":4205,"source":{"system":"sec-edgar","filing":"0001415889-20-000638","document":"form4a-03042020_020311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000638/form4a-03042020_020311.xml","form_type":"4/A","original_submission_date":"2020-01-31"}},{"id":3228304,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2020-03-04T19:30:24.000Z","date":"2020-01-30","kind":"exercise","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the restricted stock units issued to the reporting person on January 30, 2019 which have partially vested and settled for shares of the issuer's common stock.\nThe original Form 4 filed on January 31, 2020 is amended in its entirety by this Form 4 Amendment to provide the: (a) correct date the restricted stock units were first issued to the reporting person; and (b) correct disposition of the derivative securities."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001415889-20-000638","document":"form4a-03042020_020311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000638/form4a-03042020_020311.xml","form_type":"4/A","original_submission_date":"2020-01-31"}},{"id":3233648,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHIEF BUSINESS OFFICER"}}],"security":"Restricted Stock Units","published_at":"2020-03-03T23:30:20.000Z","date":"2020-02-29","kind":"exercise","acquired":false,"shares":4688,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested in accordance with the reporting person's employment agreement and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested in accordance with the reporting person's employment agreement and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested in accordance with the reporting person's employment agreement and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"As a result of reporting person's separation from the Issuer, 25% of all unvested equity accelerated in accordance with the reporting person's employment agreement and the remaining unvested equity was forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4688},"source":{"system":"sec-edgar","filing":"0001415889-20-000596","document":"form4-03032020_060306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000596/form4-03032020_060306.xml","form_type":"4"}},{"id":3233647,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2020-03-03T23:30:20.000Z","date":"2020-02-29","kind":"tax_withholding","acquired":false,"shares":1534,"price":3.13,"value":4801.42,"ownership":{"direct":true},"balance_after":7359,"source":{"system":"sec-edgar","filing":"0001415889-20-000596","document":"form4-03032020_060306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000596/form4-03032020_060306.xml","form_type":"4"}},{"id":3233646,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2020-03-03T23:30:20.000Z","date":"2020-02-29","kind":"exercise","acquired":true,"shares":4688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2019 have partially vested in accordance with the reporting person's employment agreement and settled for shares of the Issuer's common stock."}],"balance_after":8893,"source":{"system":"sec-edgar","filing":"0001415889-20-000596","document":"form4-03032020_060306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000596/form4-03032020_060306.xml","form_type":"4"}},{"id":3296893,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Restricted Stock Units","published_at":"2020-01-31T22:15:20.000Z","date":"2020-01-30","kind":"exercise","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2020 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2020 have partially vested and settled for shares of the Issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2020 have partially vested and settled for shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The remaining restricted stock units will vest ratably each quarter through January 30, 2023, subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001415889-20-000196","document":"form4-01312020_050106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000196/form4-01312020_050106.xml","form_type":"4"}},{"id":3296892,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2020-01-31T22:15:20.000Z","date":"2020-01-30","kind":"tax_withholding","acquired":false,"shares":2045,"price":3.91,"value":7995.95,"ownership":{"direct":true},"balance_after":4205,"source":{"system":"sec-edgar","filing":"0001415889-20-000196","document":"form4-01312020_050106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000196/form4-01312020_050106.xml","form_type":"4"}},{"id":3296891,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2020-01-31T22:15:20.000Z","date":"2020-01-30","kind":"exercise","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units issued to the reporting person on January 30, 2020 have partially vested and settled for shares of the Issuer's common stock."}],"balance_after":6250,"source":{"system":"sec-edgar","filing":"0001415889-20-000196","document":"form4-01312020_050106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588920000196/form4-01312020_050106.xml","form_type":"4"}},{"id":3415194,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-13T20:10:23.000Z","date":"2019-09-12","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on September 12, 2020, and the remainder vests in twelve equal quarterly installments thereafter."}],"balance_after":150000,"derivative":{"exercise_price":6.47,"expiration_date":"2029-09-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-19-001018","document":"form4-09132019_040911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919001018/form4-09132019_040911.xml","form_type":"4"}},{"id":3681480,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Restricted Stock Units","published_at":"2019-02-01T00:56:26.000Z","date":"2019-01-30","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The restricted stock units were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest as follows: 25% after first anniversary and ratably each quarter over the next three years thereafter subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances. Vested shares will be delivered promptly after each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest as follows: 25% after first anniversary and ratably each quarter over the next three years thereafter subject to the reporting person's continued employment with the Issuer, which vesting may be accelerated in certain circumstances. Vested shares will be delivered promptly after each vesting date."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-19-000114","document":"form4-01312019_040109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000114/form4-01312019_040109.xml","form_type":"4"}},{"id":3681479,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Stock Options","published_at":"2019-02-01T00:56:26.000Z","date":"2019-01-30","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued pursuant to the Issuer's 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period, with one-fourth of the shares of common stock underlying the options vesting on January 30, 2020, and the remainder vests in twelve equal quarterly installments thereafter."}],"balance_after":55000,"derivative":{"exercise_price":11.53,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001415889-19-000114","document":"form4-01312019_040109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000141588919000114/form4-01312019_040109.xml","form_type":"4"}},{"id":3883330,"issuer":{"id":7180,"kind":"organization","name":"Eloxx Pharmaceuticals, Inc."},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-27T00:52:35.000Z","date":"2018-06-25","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third (1/3) of the shares underlying the option shall vest on June 25, 2019 (the \"Cliff Vesting Date\"), the remainder of the grant shall vest in equal installments on each quarterly anniversary of the Cliff Vesting Date, subject to Reporting Person's continuous service as of each such date."}],"balance_after":200000,"derivative":{"exercise_price":18.85,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-039557","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035354/000120919118039557/doc4.xml","form_type":"4"}},{"id":4431698,"issuer":{"id":124173,"kind":"organization","name":"Radius Health, Inc.","symbol":"RDUS"},"owners":[{"id":151029,"kind":"person","name":"Snow David P.","position":1,"cik":"0001652972","reported_name":"Snow David P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-22T16:30:31.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on February 17, 2018 and the remaining shares shall vest in substantially equal monthly installments over the following three years."}],"balance_after":75000,"derivative":{"exercise_price":45.65,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-17-013269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652972/000120919117013269/doc4.xml","form_type":"4"}}]}